Resources
Scientific Publications
Presentations
Video Gallery
April 17, 2025
Preclinical immunogenicity and protective efficacy of a SARS-CoV-2 RBD based vaccine produced with the thermophilic filamentous fungal expression system Thermothelomyces heterothallica, C1
April 7, 2025
Affinity purification of SARS-CoV-2 spike protein receptor binding domain produced in a C1 fungal expression system
Investor Presentation
BIO 2025 / Boston, Massachusetts June 16-18, 2025
World Vaccine Congress / Washington DC April 23, 2025
Gates Foundation Plenary Presentation - ECI Microbial Engineering Conference, March 30, 2025
Dyadic Applied BioSolutions President & COO, Joe Hazelton, breaks down Dyadic’s near-term commercial strategy.